by Liz Trauernicht, Director MD Foundation A significant amount of evidence finds that very bright light, especially blue light, can damage the macula. Traditional slit lamp devices used during eye exams produce high light levels, which may be problematic for people with macular degeneration. Before these devices can be used effectively, the pupil of the […]
Two-year results from the recently-completed HARBOR trial showed that some patients with wet AMD fare as well from Lucentis (ranibizumab) injections on an as-needed basis compared to a monthly basis. The original Lucentis trial recommended monthly dosing until the eye stabilized. The follow-up study, however, found that 93% of patients responded well with an average […]
Payments Will Facilitate Beneficiary Access to Argus II in both Inpatient and Outpatient Settings Sylmar, CA- August 15, 2013—Second Sight Medical Products, Inc. today announced that The Argus® II Retinal Prosthesis System (Argus II) has been approved by the Centers for Medicare and Medicaid Services (CMS) beginning October 1, 2013. These payments are designed to support […]
Researchers have developed a method of delivering genes to the inner layers of the retina without the risks associated with injection into the delicate tissues themselves. This less invasive technique has been carried out successfully in animal models by a research team led by Drs. John G. Flannery and David V. Schaffer at the University […]
by Dan Roberts Updated September 2018 One of the most common problems encountered by people who are first diagnosed with macular degeneration is what to ask the doctor. The news usually takes us by surprise, and we may have never even heard of the disease before. To compound our confusion, many doctors do not have […]
A Method of Early Detection of AMD Progression by Dan Roberts Carl Zeiss Meditec, Inc. has developed a device that is proving to be an effective tool for early detection of age-related macular degeneration (AMD). Called the PreView PHP™ (Preferential Hyperacuity Perimetry), it identifies deviations in the retina using a vision test based upon the […]
Presented to the International Low Vision Support Group by Dan Roberts July 2013 [Opening: montage of screen shots and audio of disclaimers from drug commercials] Pretty scary, isn’t it? Kind of like telling us we’re going to feel better or die trying. These commercials, which show peaceful scenes of happy people while a disembodied voice […]
Betadine (povidone-iodine 5%) has become the standard of care for cleansing the eye during anti-VEGF injection procedures. Though the incidence of sensitivity to povidone-iodine (PVPI) is infrequent, some patients are reporting severe and prolonged burning of the conjunctiva.1, 2, 3 Even though the complaints are relatively few, a solution needs to be found to this […]
by Dan Roberts Originally published and updated, April 6, 2013 This is a continuously updated review of research since 2002 on cholesterol and age-related macular degeneration. It presents studies of statin treatment and it introduces recent findings regarding reduction of cholesterol by restoring macrophages. Statins Statins are a type of cholesterol-reducing drug that lower the […]
by Dan Roberts (Updated April 29, 2015) (Reviewed by Martin A. Mainster, Ph.D., M.D., FRCOphth) Audio/visual presentations on all related subjects Recommended books: The First Year: Age-Related Macular Degeneration: An Essential Guide for the Newly Diagnosed by Daniel L. Roberts Macular Degeneration: The Complete Guide to Saving and Maximizing Your Sight by Lylas Mogk, M.D. […]